Advanced Filters
noise

sterilization Clinical Trials

A listing of sterilization medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 12 clinical trials
R Randa Jalloul, MD

Patient-centered Outcomes After Permanent Female Sterilization Procedure(POPS Trial)

The purpose of this study is to compare and capture key elements of the patient experience, quality of recovery, preferences and satisfaction after laparoscopic salpingectomy done via 3 different routes.

18 - 55 years of age Female Phase N/A

Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp

Group I (Experimental group I): Lesion Sterilization and Tissue Repair with radicular instrumentation. Coronal and accessible radicular pulp tissue are extirpated using rotary files. After proper drying, the paste is placed in the cavity and canals. Group II (Experimental group II): Lesion Sterilization and Tissue Repair with no radicular instrumentation. …

4 - 8 years of age Both Phase N/A

Topical Infliximab for Sterile Corneal Melt

Corneal melt is a complication that could affect very ill eyes and lead to the thinning of the cornea (the clear window covering of the eyes). This thinning can lead to severe consequences such as the leakage of the liquid inside the eye (ocular perforation), or even blindness. Corneal melt …

18 - 80 years of age Both Phase 1

Uterus Transplantation Procedure From a Live Donor

Absolut uterine factor, meaning the absence of uterus, represents a cause for sterility without the possibility of a present treatment. The uterine factor affects millions of women and may be due to congenital problems, such as the Muller anomalies (Mayer Rockitansky Syndrome) or acquired by previous hysterectomy or intrauterine adhesions …

18 - 65 years of age Female Phase N/A
A Ayman Dawood, MD

Dysfunctional Uterine Bleeding After Tubal Sterilization

In this study, the investigators will compare the frequency and amount of bleeding after tubal sterilization and salpingectomy

20 - 40 years of age Female Phase N/A
F François CLOSON

Vaginal Natural Orifice Trans-luminal Endoscopic Surgery Salpingectomy for Tubal Sterilization: Clinical Outcomes and Learning Curve Analysis

The evolution from classical open surgery to laparoscopic surgery has led to a significant reduction of morbidity and mortality. Newer advances such as development of single port laparoscopic surgery and scarless Natural Orifice Transluminal Endoscopic Surgery (NOTES) have moved forward the practice in "Minimally Invasive Surgery". Recently, clinical application of …

18 - 50 years of age Female Phase N/A
M MONICA TORIBIO

Evaluation of Salivary ELISA for Hormone Monitoring in Donors

In donors or patients undergoing assisted reproduction treatments (ART) it is necessary to closely control ovarian stimulation to monitor the number and size of developing follicles. Oestradiol (E2) and progesterone (P4) are products of steroidogenesis. Their concentrations increase with the diameter of the growing follicle. In order to assess treatment …

18 - 35 years of age Female Phase N/A
M Mostafa Borahay, MD, PhD

Opioid Use After Laparoscopic Salpingectomy

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, …

18 - 100 years of age Female Phase N/A
T Tanja Eggersmann, MD

Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation

The primary objective is to investigate the efficacy, defined as an increase in oocyte numbers upon ovarian stimulation, and safety of a single intra-ovarian PRP injection vs. saline solution (NaCl) injection (Placebo) transvaginally or laparoscopically for follicular activation in patients with child wish and with low ovarian reserve/expected poor ovarian …

18 - 42 years of age Female Phase N/A
A Agni Pantou, M.D

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.

35 - 47 years of age Female Phase 2/3

Rewrite in simple language using AI